Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
82.8 USD | -0.83% | +3.93% | +7.26% |
May. 06 | Argus Adjusts Price Target on Bio-Techne to $95 From $90, Keeps Buy Rating | MT |
May. 02 | UBS Adjusts Price Target on Bio-Techne to $90 From $80, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.26% | 13.16B | |
+29.46% | 49.46B | |
+0.70% | 42.58B | |
+48.83% | 42.49B | |
-5.26% | 29.09B | |
+12.42% | 26.61B | |
-24.25% | 18.64B | |
+31.96% | 12.55B | |
+23.79% | 12.1B | |
-5.37% | 11.98B |
- Stock Market
- Equities
- TECH Stock
- News Bio-Techne Corporation
- RBC Capital Adjusts Price Target on Bio-Techne to $71 From $79